XML 27 R17.htm IDEA: XBRL DOCUMENT v3.25.3
EARNINGS PER SHARE ("EPS")
 9 Months Ended
Oct. 03, 2025
EARNINGS PER SHARE (EPS)  
EARNINGS PER SHARE (EPS)

11. EARNINGS PER SHARE (“EPS”)

Basic EPS is computed by dividing net income available to common stockholders by the weighted-average number of common shares outstanding. Diluted EPS is computed by dividing net income by the weighted-average number of common shares outstanding and dilutive potential common shares for the period. Potential common shares include the weighted-average dilutive effects of outstanding stock options and restricted stock awards using the treasury stock method.

The following table sets forth the number of weighted-average common shares outstanding used to compute basic and diluted EPS:

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Three months ended

​

Nine months ended

​

​

October 3,

​

September 27,

​

October 3,

​

September 27,

​

    

2025

    

2024

    

2025

    

2024

​

​

(in thousands, except per share amounts)

Net income (loss)

​

$

13,721

​

$

7,346

​

$

33,844

​

$

14,882

Weighted-average common shares outstanding

​

 

14,603

​

 

13,930

​

 

14,397

​

 

13,753

Effect of dilutive stock options and restricted stock awards

​

 

626

​

 

428

​

 

590

​

 

377

Weighted-average common shares outstanding-diluted

​

 

15,229

​

 

14,358

​

 

14,987

​

 

14,130

Earnings (Loss) per share:

​

​

​

​

​

​

​

​

​

​

​

​

Basic

​

$

0.94

​

$

0.53

​

$

2.35

​

$

1.08

Diluted

​

$

0.90

​

$

0.51

​

$

2.26

​

$

1.05

 

​

For the three months ended October 3, 2025, the Company did not exclude any shares subject to outstanding equity awards from the calculation of diluted shares. For the nine months ended October 3, 2025, the Company excluded 2,000 common shares subject to outstanding equity awards from the calculation of diluted shares because their impact would have been anti-dilutive. For the three months ended September 27, 2024, the Company did not exclude any shares subject to outstanding equity awards from the calculation of diluted shares. For the nine months ended September 27, 2024, the Company excluded 269,000 common shares subject to outstanding equity awards from the calculation of diluted shares because their impact would have been anti-dilutive.

​